- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 636
Goldman Sachs helps sit $60m in Citixsys
The retail and hospitality management platform developer raised $60m in a Goldman Sachs-led round that took its total funding to at least $105m.
Nov 27, 2019Corporates drop into Swat's series A
On-demand bus transportation service Swat secured $10.1m in a round backed by public transit operators SMRT and ComfortDelGro that will fund geographical expansion and recruitment.
Nov 27, 2019Shuttl shoots to $36m for series C
The bus transportation provider's series C round currently stands at $36m, half of which has come from Toyota Tsusho and Mirai Creation Fund.
Nov 27, 2019Loom loots $30m in series B round
The Slack-backed enterprise video messaging platform took its total funding to $45m with a Sequoia-led round that will fund product development.
Nov 27, 2019NetEase tosses funding to Bossa
NetEase has led a series B round for the game developer reportedly sized at up to $30m and will now help it expand into China.
Nov 27, 2019Heartseed to grow with series B funding
JMDC, Gene Techno Science, Astellas Venture Management and Nissay Capital have contributed to a $25.8m round for Keio University's heart failure treatment developer.
Nov 26, 2019Daily deal net: November 26, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Nov 26, 2019Advanced Navigation guides through $13.6m
University of Western Australia-founded automated navigation business Advanced Navigation will look to win custom in the US and Europe for its products, which operate in areas unreachable by GPS.
Nov 26, 2019V2Food tucks into $23.8m series A
V2Food has secured series A funding on the back of its strategic partnership with burger retail chain Hungry Jack's.
Nov 26, 2019FerGene secures $570m for first funding
FerGene has been spun off by Ferring Pharmaceuticals to bring a gene therapy for bladder cancer to market, and Ferring itself is supplying $170m of the cash.
Nov 26, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


